FTP7.12 Percutaneous Cholecystostomy use at ESHT

Abstract Aim Percutaneous Cholecystostomy is a well-recognised adjunct to antibiotic therapy in management of acute calculous cholecystitis – often as temporising measure definitive surgery. Multiple guidelines exist advising on patient selection and timing insertion, however little evidence exists managing these following interval cholecystectomy, investigations prior removal. Method A closed-loop retrospective review all patients undergoing radiologically guided PC insertion between 01/06/2015-31/05/2017 (Cycle 1) 01/11/2021-01/12/2022 2) at ESHT. Data collected included demographics, time from diagnosis PC, duration admission situ Results 43 across both cycles, with average age 72, (median 74, range 50-92). Cycle 1 consisted 26 patients, whereas 2 had 17 patients. Duration was longer (Average: 10 vs 8.5, Median: 9.5 6, Range: 3-21 vs. 1-26 days). Time similar 2.7 3, 1, 0-12 0-25 cholecystostomy 41, 21 32, 7-95 1-196 53% (n=17) underwent cholecystogram removal 12% (n=3) 1. Conclusions We identified considerable heterogeneity within practice surrounding the Considering this we are introducing trust-wide “Cholecystostomy Management” Pathway standardise our practice, Passport” for outlining providing safety netting information emergency contact details.